1.
Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients
2.
3.
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
4.
5.
A decade of biologic treatment observation in juvenile idiopathic arthritis: Lessons learned from the Dutch ABC Register
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Tr...
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice.
Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progressio...
6.
7.
8.
9.
